OncoCyte Corp Uncategorized Contracts & Agreements
19 Contracts & Agreements
- Collaboration Agreement, dated April 5, 2024, between the Company and Bio-Rad Laboratories, Inc (Filed With SEC on May 15, 2024)
- Description of Securities (Filed With SEC on April 16, 2024)
- Description of Securities (Filed With SEC on April 12, 2023)
- Description of Securities (Filed With SEC on March 11, 2022)
- Addendum No. 2 to Exclusive Sublicense Agreement in the PRC Territory, dated December 5, 2021, by and among Razor Genomics, Inc., Oncocyte Corporation, Encore Clinical, Inc., and... (Filed With SEC on December 8, 2021)
- Description of Securities (Filed With SEC on March 19, 2021)
- Exclusive Sublicense Agreement in the PRC Territory (Filed With SEC on December 16, 2020)
- Reduction in Salary Agreement between OncoCyte Corporation and Tony Kalajian (Filed With SEC on September 28, 2020)
- Reduction in Salary Agreement between OncoCyte Corporation and Lyndal Hesterberg (Filed With SEC on September 28, 2020)
- Reduction in Salary Agreement between OncoCyte Corporation and Albert Parker (Filed With SEC on September 28, 2020)
- Acknowledgement and Agreement, dated May 7, 2020, between OncoCyte Corporation and Lyndal Hesterberg (Filed With SEC on May 12, 2020)
- Acknowledgement and Agreement, dated May 7, 2020, between OncoCyte Corporation and Mitchell Levine (Filed With SEC on May 12, 2020)
- Acknowledgement and Agreement, dated May 7, 2020, between OncoCyte Corporation and Ronald Andrews (Filed With SEC on May 12, 2020)
- Description of Securities (Filed With SEC on March 26, 2020)
- Engagement Agreement, dated July 26, 2018, by and between OncoCyte Corporation and Chardan Capital Markets, LLC (Filed With SEC on August 1, 2018)
- WARRANTEXERCISE AGREEMENT (Filed With SEC on July 26, 2017)
- WARRANTEXERCISE AGREEMENT (Filed With SEC on July 26, 2017)
- WARRANTEXERCISE AGREEMENT (Filed With SEC on July 26, 2017)
- Form of Warrants (Filed With SEC on August 29, 2016)
